Cargando…

Preparation of Coated Valproic Acid and Sodium Valproate Sustained-release Matrix Tablets

The aim of this research was to investigate the technique for preparation of coated valproic acid and sodium valproate sustained-release matrix tablets. Different diluents were tested and selected as the effective absorbent for oily valproic acid. Effect of the amount of absorbent and hydroxypropylm...

Descripción completa

Detalles Bibliográficos
Autores principales: Phaechamud, T., Mueannoom, W., Tuntarawongsa, S., Chitrattha, S.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929775/
https://www.ncbi.nlm.nih.gov/pubmed/20838520
http://dx.doi.org/10.4103/0250-474X.65026
_version_ 1782185955206103040
author Phaechamud, T.
Mueannoom, W.
Tuntarawongsa, S.
Chitrattha, S.
author_facet Phaechamud, T.
Mueannoom, W.
Tuntarawongsa, S.
Chitrattha, S.
author_sort Phaechamud, T.
collection PubMed
description The aim of this research was to investigate the technique for preparation of coated valproic acid and sodium valproate sustained-release matrix tablets. Different diluents were tested and selected as the effective absorbent for oily valproic acid. Effect of the amount of absorbent and hydroxypropylmethylcellulose on drug release from valproic acid-sodium valproate matrix tablets prepared with wet granulation technique was evaluated in pH change system. Colloidal silicon dioxide effectively adsorbed liquid valproic acid during wet granulation and granule preparation. The amounts of colloidal silicon dioxide and hydroxypropylmethylcellulose employed in tablet formulations affected drug release from the tablets. The drug release was prominently sustained for over 12 h using hydroxypropylmethylcellulose-based hydrophilic matrix system. The mechanism of drug release through the matrix polymer was a diffusion control. The drug release profile of the developed matrix tablet was similar to Depakine Chrono(®), providing the values of similarity factor (f2) and difference factor (f1) of 85.56 and 2.37, respectively. Eudragit(®) L 30 D-55 was used as effective subcoating material for core matrix tablets before over coating with hydroxypropylmethylcellulose film with organic base solvent. Drug release profile of coated matrix tablet was almost similar to that of Depakine Chrono(®).
format Text
id pubmed-2929775
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-29297752010-09-13 Preparation of Coated Valproic Acid and Sodium Valproate Sustained-release Matrix Tablets Phaechamud, T. Mueannoom, W. Tuntarawongsa, S. Chitrattha, S. Indian J Pharm Sci Research Paper The aim of this research was to investigate the technique for preparation of coated valproic acid and sodium valproate sustained-release matrix tablets. Different diluents were tested and selected as the effective absorbent for oily valproic acid. Effect of the amount of absorbent and hydroxypropylmethylcellulose on drug release from valproic acid-sodium valproate matrix tablets prepared with wet granulation technique was evaluated in pH change system. Colloidal silicon dioxide effectively adsorbed liquid valproic acid during wet granulation and granule preparation. The amounts of colloidal silicon dioxide and hydroxypropylmethylcellulose employed in tablet formulations affected drug release from the tablets. The drug release was prominently sustained for over 12 h using hydroxypropylmethylcellulose-based hydrophilic matrix system. The mechanism of drug release through the matrix polymer was a diffusion control. The drug release profile of the developed matrix tablet was similar to Depakine Chrono(®), providing the values of similarity factor (f2) and difference factor (f1) of 85.56 and 2.37, respectively. Eudragit(®) L 30 D-55 was used as effective subcoating material for core matrix tablets before over coating with hydroxypropylmethylcellulose film with organic base solvent. Drug release profile of coated matrix tablet was almost similar to that of Depakine Chrono(®). Medknow Publications 2010 /pmc/articles/PMC2929775/ /pubmed/20838520 http://dx.doi.org/10.4103/0250-474X.65026 Text en © Indian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Phaechamud, T.
Mueannoom, W.
Tuntarawongsa, S.
Chitrattha, S.
Preparation of Coated Valproic Acid and Sodium Valproate Sustained-release Matrix Tablets
title Preparation of Coated Valproic Acid and Sodium Valproate Sustained-release Matrix Tablets
title_full Preparation of Coated Valproic Acid and Sodium Valproate Sustained-release Matrix Tablets
title_fullStr Preparation of Coated Valproic Acid and Sodium Valproate Sustained-release Matrix Tablets
title_full_unstemmed Preparation of Coated Valproic Acid and Sodium Valproate Sustained-release Matrix Tablets
title_short Preparation of Coated Valproic Acid and Sodium Valproate Sustained-release Matrix Tablets
title_sort preparation of coated valproic acid and sodium valproate sustained-release matrix tablets
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929775/
https://www.ncbi.nlm.nih.gov/pubmed/20838520
http://dx.doi.org/10.4103/0250-474X.65026
work_keys_str_mv AT phaechamudt preparationofcoatedvalproicacidandsodiumvalproatesustainedreleasematrixtablets
AT mueannoomw preparationofcoatedvalproicacidandsodiumvalproatesustainedreleasematrixtablets
AT tuntarawongsas preparationofcoatedvalproicacidandsodiumvalproatesustainedreleasematrixtablets
AT chitratthas preparationofcoatedvalproicacidandsodiumvalproatesustainedreleasematrixtablets